You are planning a Phase II oncology study across three APAC markets. The protocol is close to final. Now comes the part most sponsors underestimate: selecting a CRO model that gives you execution control without building infrastructure you do not have. A full service CRO APAC engagement hands you one accountable partner across every function, […]
Read More →The Asia-Pacific region is home to a diverse array of traditional medicinal practices. The region is also rich in a large and diverse population. This diversity includes genetic variations, dietary patterns, environmental factors, and disease profiles, which makes trial results more applicable across global populations. Moreover, the growth of research facilities presents opportunities for sponsors […]
Read More →Bioavailability and bioequivalence (BA/BE) studies in the Asia-Pacific region are gaining significant momentum. The rising cost of medicines worldwide is driving a strong demand for more affordable healthcare options. In this context, the generic drug market is emerging as a promising alternative, offering consumers access to medications at more reasonable prices. To bring generic drugs […]
Read More →Pharmaceutical research and development in the Asia-Pacific (APAC) region now heavily relies on clinical trial sourcing. Collaborating with research institutions and healthcare organizations fosters international research partnerships and facilitates knowledge exchange. Most countries in the Asia-Pacific region tend to seek this help because it brings several benefits. The success of clinical trials depends on the […]
Read More →Navigating the Asia-Pacific generic drug market involves grappling with regulatory requirements and overcoming diverse challenges. Stakeholders navigate a dynamic landscape, from strict safety standards to complex supply chains and pricing pressures, demanding adaptability and strategic maneuvering for success. Generic drugs surge globally for their cost-effectiveness, bioequivalence to brand-name counterparts, and adherence to stringent safety, efficacy, […]
Read More →The Asia-Pacific region, with its growing population, growing healthcare needs, and attempts to cut costs, is one of the major players in the generic drug market. In recent years, the Asia-Pacific region has seen a significant push towards using generic medications to cut costs and improve efficiency in healthcare systems. This trend is evident across […]
Read More →The APAC region has had a remarkable increase in oncology clinical trial activity, and it is currently leading the world in the overall number of ongoing oncology clinical studies. The Asia-Pacific region has emerged as an epicenter of clinical trial activity, accounting for over half of total global clinical trials. With these growth tendencies projected […]
Read More →Nutraceutical clinical trials are steadily increasing in the Asia-Pacific region. The nutraceutical market in the Asia-Pacific is experiencing tremendous growth and is expected to expand further. The Asia-Pacific region, encompassing countries like Australia, India, Japan, and China, offers significant opportunities for the nutraceutical market due to its large population, rising disposable income, and growing focus […]
Read More →The Asia-Pacific region, with over half of the global population, is becoming a growing popular spot for conducting clinical trials by offering lower trial costs, access to large patient pools, and a friendly regulatory environment. These distinguishing traits are increasing interest in medical device, pharmaceutical, and healthcare companies to shift their clinical trial locations to […]
Read More →Comprehending the function of clinical trial investigators and the accessibility of appropriate trial sites is essential, as it signifies the commencement of the market availability of your healthcare product following a successful clinical trial. The Asia-Pacific region is gaining prominence in the world of healthcare products. The healthcare market in the Asia-Pacific region is expected […]
Read More →